FDA Approves Eye Implant to Correct Presbyopia in Middle Age

Share this content:
FDA Approves Eye Implant to Correct Presbyopia in Middle Age
FDA Approves Eye Implant to Correct Presbyopia in Middle Age

THURSDAY, June 30, 2016 (HealthDay News) -- An implant that helps the aging eye focus on small print and nearby objects has been approved by the U.S. Food and Drug Administration.

The implant is placed in the cornea of one eye in patients with presbyopia. It resembles a tiny contact lens smaller than the eye of a needle. It is approved for use in individuals aged 41 to 65 who have not had cataract surgery, can't focus clearly on near objects or small print, and require reading glasses with +1.50 to +2.50 diopters of power, the FDA said. But these patients do not need glasses or contacts for long-distance vision.

The FDA's approval of the Raindrop implant -- made by California-based Revision Optics, Inc. -- is based on a clinical trial of 373 patients. Two years after receiving the implant, 92 percent of the patients were able to see with 20/40 vision or better at near distances with the implant, according to the FDA.

The implant can cause or worsen problems with glare and halos, the FDA added. And there is a risk of developing infections that may cause complications of the cornea, such as corneal scarring, swelling, inflammation, thinning, clouding, or melting. Some patients may require a second surgery to remove or replace the inlay, the agency said.

More Information

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Ground Beef Recalled After E. Coli Outbreak

Ground Beef Recalled After <i>E. Coli</i> Outbreak

Beef was produced and packaged at Cargill Meat Solutions in Fort Morgan, Colo.

Prevalence of Alzheimer's, Related Dementia Set to Double

Prevalence of Alzheimer's, Related Dementia Set to Double

Alzheimer's disease and related dementias burden is expected to increase to 3.3 percent in 2060

Long-Term Outcomes of Breast Implants Explored

Long-Term Outcomes of Breast Implants Explored

Higher rates of Sjogren syndrome, scleroderma, RA, stillbirth, melanoma for silicone implants

is free, fast, and customized just for you!




Already a member?

Sign In Now »